South African tycoon Stephen Saad's Aspen sells menopause drug rights for $220 million
Billionaires Africa | 03.11.2026 01:22
Aspen Pharmacare Holdings Ltd., the drugmaker led by South African tycoon Stephen Saad, has agreed to sell the European rights to its menopause treatment Ovestin for €197 million ($220 million), as it sells off assets outside its core emerging markets.
